• OPEN AN ACCOUNT
Indian Indices
Nifty
24,718.60 -169.60
(-0.68%)
Sensex
81,118.60 -573.38
( -0.70%)
Bank Nifty
55,527.35 -555.20
( -0.99%)
Nifty IT
38,469.25 8.95
( 0.02%)
Global Indices
Nasdaq
42,214.73 -773.90
(-1.80%)
Dow Jones
5,997.34 -68.92
(-1.14%)
Hang Seng
37,801.43 -371.66
(-0.97%)
Nikkei 225
8,850.63 -34.29
(-0.39%)
Forex
USD-INR
85.55 0.07
(0.08%)
EUR-INR
98.89 0.98
(1.00%)
GBP-INR
116.24 0.70
(0.61%)
JPY-INR
0.60 0.01
(0.86%)

EQUITY - MARKET SCREENER

Albert David Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524075
INE155C01010
687.3730298
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ALBERTDAVD
28.6
491.86
EPS(TTM)
Face Value()
Div & Yield %
30.12
10
0.58
 

Indrayani Biotech Ltd - Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For Quarter And Year Ended 31St March 2025 To Be Held On 9Th June 2025
May 27,2025
Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2025 inter alia to consider and approve audited financial results (standalone and consolidated) for quarter and year ended 31st March 2025